We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LLY market cap is 742.17B. The company's latest EPS is USD 5.5153 and P/E is 141.62.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.94B | 7.3B | 6.96B | 8.31B | 9.5B |
| Operating Income | 1.88B | 1.87B | 1.49B | 2.13B | -3.24B |
| Net Income | 1.45B | 1.94B | 1.34B | 1.76B | -57.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.32B | 24.56B | 28.32B | 28.54B | 34.12B |
| Operating Income | 5.47B | 6.06B | 6.66B | 7.37B | 6.46B |
| Net Income | 8.32B | 6.19B | 5.58B | 6.24B | 5.24B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 47.46B | 49.49B | 53.16B | 54.81B | 57.92B |
| Total Liabilities | 37.3B | 38.71B | 41.87B | 43.66B | 46.61B |
| Total Equity | 10.17B | 10.78B | 11.29B | 11.15B | 11.31B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 39.29B | 46.63B | 48.81B | 49.49B | 64.01B |
| Total Liabilities | 36.59B | 40.81B | 39.65B | 38.71B | 53.14B |
| Total Equity | 2.7B | 5.83B | 9.15B | 10.78B | 10.86B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.5B | 7.08B | 1.73B | 2.36B | 4.55B |
| Investing | -2.4B | -3.26B | -688.8M | -1.15B | -4.23B |
| Financing | -4.27B | -5.41B | 412.3M | -621.1M | -49.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.84B | 6.5B | 7.26B | 7.08B | 4.24B |
| Investing | -8.08B | -2.26B | -2.76B | -3.26B | -7.15B |
| Financing | -2.32B | -3.14B | -4.13B | -5.41B | 3.5B |
| Market Cap | 742.17B |
| Price to Earnings Ratio | 141.62 |
| Price to Sales Ratio | 21.75 |
| Price to Cash Ratio | 263.32 |
| Price to Book Ratio | 68.32 |
| Dividend Yield | 0.60% |
| Shares Outstanding | 950.16M |
| Average Volume (1 week) | 3.38M |
| Average Volume (1 Month) | 2.6M |
| 52 Week Change | 96.59% |
| 52 Week High | 800.78 |
| 52 Week Low | 392.255 |
| Spread (Intraday) | 0.42 (0.05%) |
| Company Name | Eli Lilly and Co |
| Address |
334 north senate avenue indianapolis, indiana 46204 |
| Website | https://www.lilly.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
